| Theatrical Performance (US$) | ||
| China Box Office | $944,091 | Details |
| Worldwide Box Office | $944,091 | Details |
| Further financial details... | ||
| China Releases: | August 1st, 2024 (Limited) June 10th, 2025 (Limited) |
| Running Time: | 90 minutes |
| Source: | Based on Real Life Events |
| Genre: | Drama |
| Production Method: | Live Action |
| Creative Type: | Historical Fiction |
| Production Countries: | China |
| Languages: | Mandarin |
Because some of our sources provide box office data in their local currency, while we use USD in the graph above and table below, exchange rate fluctuations can have effect on the data causing stronger increases or even decreases of the cumulative box office.
| Date | Rank | Gross | % Change | Screens | Per Screen | Total Gross | Week |
|---|---|---|---|---|---|---|---|
| 2024/08/02 | 18 | $35,335 | 0 | $134,497 | 1 | ||
| 2024/08/09 | 26 | $14,095 | -60% | 0 | $177,784 | 2 | |
| 2024/08/16 | 23 | $21,774 | +54% | 0 | $230,585 | 3 | |
| 2024/08/23 | 28 | $21,054 | -3% | 0 | $288,445 | 4 | |
| 2024/08/30 | 36 | $10,719 | -49% | 0 | $332,722 | 5 | |
| 2024/09/06 | 48 | $2,962 | -72% | 0 | $342,570 | 6 | |
| 2024/09/13 | 32 | $12,970 | +338% | 0 | $365,290 | 7 | |
| 2024/09/27 | 24 | $23,677 | 0 | $441,300 | 9 | ||
| 2025/06/13 | 27 | $8,495 | 0 | $504,247 | 46 | ||
| 2025/06/20 | 19 | $23,682 | +179% | 0 | $554,851 | 47 | |
| 2025/06/27 | 17 | $63,580 | +168% | 0 | $678,602 | 48 | |
| 2025/07/04 | 20 | $26,227 | -59% | 0 | $850,957 | 49 | |
| 2025/07/11 | 29 | $9,627 | -63% | 0 | $891,729 | 50 | |
| 2025/07/25 | 34 | $3,628 | 0 | $923,841 | 52 |
| Territory | Release Date |
Opening Weekend |
Opening Weekend Screens |
Maximum Screens |
Theatrical Engagements |
Total Box Office |
Report Date |
|---|---|---|---|---|---|---|---|
| China | 8/1/2024 | $35,335 | 0 | 0 | 0 | $944,091 | 11/7/2025 |
| Worldwide Total | $944,091 | 11/7/2025 | |||||
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue are available through our research services at a cost. For more information, please contact us at research@the-numbers.com.
| Mingxi Tao (陶明喜) | Director |
